Annual Operating Profit
-$11.46 M
+$8.80 M+43.44%
31 December 2023
Summary:
Processa Pharmaceuticals annual operaing income is currently -$11.46 million, with the most recent change of +$8.80 million (+43.44%) on 31 December 2023. During the last 3 years, it has fallen by -$5.02 million (-77.99%). PCSA annual operating profit is now -15923.92% below its all-time high of -$71.50 thousand, reached on 31 December 2016.PCSA Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
-$3.42 M
-$342.90 K-11.13%
30 September 2024
Summary:
Processa Pharmaceuticals quarterly operating income is currently -$3.42 million, with the most recent change of -$342.90 thousand (-11.13%) on 30 September 2024. Over the past year, it has dropped by -$1.26 million (-58.00%). PCSA quarterly operating profit is now -2616.46% below its all-time high of $136.10 thousand, reached on 31 December 2014.PCSA Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
-$11.79 M
-$1.26 M-11.94%
30 September 2024
Summary:
Processa Pharmaceuticals TTM operating income is currently -$11.79 million, with the most recent change of -$1.26 million (-11.94%) on 30 September 2024. Over the past year, it has increased by +$3.00 million (+20.30%). PCSA TTM operating profit is now -120165.31% below its all-time high of -$9800.00, reached on 31 March 2017.PCSA TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCSA Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +43.4% | -58.0% | +20.3% |
| 3 y3 years | -78.0% | -11.9% | +0.9% |
| 5 y5 years | -153.2% | -241.1% | -213.0% |
PCSA Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -78.0% | +43.4% | -58.0% | +43.5% | -16.0% | +44.2% |
| 5 y | 5 years | -191.1% | +43.4% | -327.0% | +43.5% | -222.4% | +44.2% |
| alltime | all time | <-9999.0% | +43.4% | -2616.5% | +43.5% | <-9999.0% | +44.2% |
Processa Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.42 M(+11.1%) | -$11.79 M(+11.9%) |
| June 2024 | - | -$3.08 M(+9.7%) | -$10.53 M(+3.6%) |
| Mar 2024 | - | -$2.81 M(+13.8%) | -$10.16 M(-11.3%) |
| Dec 2023 | -$11.46 M(-43.4%) | -$2.47 M(+13.9%) | -$11.46 M(-22.5%) |
| Sept 2023 | - | -$2.17 M(-20.1%) | -$14.79 M(-20.8%) |
| June 2023 | - | -$2.71 M(-33.9%) | -$18.68 M(-11.6%) |
| Mar 2023 | - | -$4.11 M(-29.2%) | -$21.13 M(+4.3%) |
| Dec 2022 | -$20.26 M(+75.1%) | -$5.80 M(-4.2%) | -$20.26 M(+13.6%) |
| Sept 2022 | - | -$6.06 M(+17.1%) | -$17.83 M(+20.2%) |
| June 2022 | - | -$5.17 M(+60.2%) | -$14.83 M(+17.7%) |
| Mar 2022 | - | -$3.23 M(-4.2%) | -$12.60 M(+9.0%) |
| Dec 2021 | -$11.57 M(+79.7%) | -$3.37 M(+10.1%) | -$11.57 M(-2.7%) |
| Sept 2021 | - | -$3.06 M(+4.0%) | -$11.89 M(+21.5%) |
| June 2021 | - | -$2.94 M(+34.2%) | -$9.79 M(+28.0%) |
| Mar 2021 | - | -$2.19 M(-40.6%) | -$7.64 M(+18.8%) |
| Dec 2020 | -$6.44 M(+63.6%) | -$3.69 M(+286.5%) | -$6.44 M(+76.1%) |
| Sept 2020 | - | -$955.50 K(+19.1%) | -$3.66 M(-1.3%) |
| June 2020 | - | -$802.00 K(-18.7%) | -$3.70 M(-8.3%) |
| Mar 2020 | - | -$986.10 K(+8.1%) | -$4.04 M(+2.6%) |
| Dec 2019 | -$3.94 M(-13.0%) | -$912.00 K(-9.2%) | -$3.94 M(+4.5%) |
| Sept 2019 | - | -$1.00 M(-11.7%) | -$3.77 M(-1.5%) |
| June 2019 | - | -$1.14 M(+28.8%) | -$3.82 M(-7.1%) |
| Mar 2019 | - | -$882.50 K(+19.0%) | -$4.12 M(-9.0%) |
| Dec 2018 | -$4.52 M | -$741.90 K(-30.2%) | -$4.52 M(-16.2%) |
| Sept 2018 | - | -$1.06 M(-25.6%) | -$5.40 M(+20.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2018 | - | -$1.43 M(+10.6%) | -$4.50 M(+46.0%) |
| Mar 2018 | - | -$1.29 M(-20.0%) | -$3.08 M(+70.9%) |
| Dec 2017 | -$1.80 M(+2420.8%) | -$1.61 M(+885.7%) | -$1.80 M(+960.3%) |
| Sept 2017 | - | -$163.80 K(+1475.0%) | -$170.00 K(+1417.9%) |
| June 2017 | - | -$10.40 K(-24.1%) | -$11.20 K(+14.3%) |
| Mar 2017 | - | -$13.70 K(-176.5%) | -$9800.00(-86.3%) |
| Dec 2016 | -$71.50 K(-92.8%) | $17.90 K(-458.0%) | -$71.60 K(-59.1%) |
| Sept 2016 | - | -$5000.00(-44.4%) | -$175.10 K(-27.2%) |
| June 2016 | - | -$9000.00(-88.1%) | -$240.40 K(-60.2%) |
| Mar 2016 | - | -$75.50 K(-11.8%) | -$604.20 K(-38.8%) |
| Dec 2015 | -$987.20 K(-54.2%) | -$85.60 K(+21.8%) | -$987.10 K(+29.0%) |
| Sept 2015 | - | -$70.30 K(-81.1%) | -$765.40 K(-43.6%) |
| June 2015 | - | -$372.80 K(-18.7%) | -$1.36 M(-21.2%) |
| Mar 2015 | - | -$458.40 K(-436.8%) | -$1.72 M(-20.2%) |
| Dec 2014 | -$2.16 M(-27.1%) | $136.10 K(-120.6%) | -$2.16 M(-30.1%) |
| Sept 2014 | - | -$661.80 K(-10.4%) | -$3.09 M(-0.4%) |
| June 2014 | - | -$738.30 K(-17.4%) | -$3.10 M(+1.5%) |
| Mar 2014 | - | -$893.60 K(+12.7%) | -$3.05 M(+3.1%) |
| Dec 2013 | -$2.96 M(+30.3%) | -$792.60 K(+17.5%) | -$2.96 M(+0.9%) |
| Sept 2013 | - | -$674.40 K(-2.7%) | -$2.94 M(+3.8%) |
| June 2013 | - | -$693.20 K(-13.5%) | -$2.83 M(+11.3%) |
| Mar 2013 | - | -$801.10 K(+4.4%) | -$2.54 M(+11.8%) |
| Dec 2012 | -$2.27 M | -$767.60 K(+35.1%) | -$2.27 M(+51.0%) |
| Sept 2012 | - | -$568.10 K(+40.2%) | -$1.51 M(+60.6%) |
| June 2012 | - | -$405.20 K(-23.8%) | -$937.10 K(+76.2%) |
| Mar 2012 | - | -$531.90 K | -$531.90 K |
FAQ
- What is Processa Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals annual operating profit year-on-year change?
- What is Processa Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals quarterly operating profit year-on-year change?
- What is Processa Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Processa Pharmaceuticals?
- What is Processa Pharmaceuticals TTM operating profit year-on-year change?
What is Processa Pharmaceuticals annual operaing income?
The current annual operating profit of PCSA is -$11.46 M
What is the all time high annual operating profit for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high annual operaing income is -$71.50 K
What is Processa Pharmaceuticals annual operating profit year-on-year change?
Over the past year, PCSA annual operaing income has changed by +$8.80 M (+43.44%)
What is Processa Pharmaceuticals quarterly operating income?
The current quarterly operating profit of PCSA is -$3.42 M
What is the all time high quarterly operating profit for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high quarterly operating income is $136.10 K
What is Processa Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, PCSA quarterly operating income has changed by -$1.26 M (-58.00%)
What is Processa Pharmaceuticals TTM operating income?
The current TTM operating profit of PCSA is -$11.79 M
What is the all time high TTM operating profit for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high TTM operating income is -$9800.00
What is Processa Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, PCSA TTM operating income has changed by +$3.00 M (+20.30%)